Showing 561 - 580 results of 46,618 for search '(( a ((laser decrease) OR (mean decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 0.97s Refine Results
  1. 561
  2. 562
  3. 563

    Flowchart of study participants. by Masoumeh Sayahi (17468290)

    Published 2024
    “…Also, on day 14 post-intervention, there was a significant decrease between the groups of intervention and control in terms of the mean score of episiotomy wound healing (REEDA index) (0.53 ± 0.77, 1.77 ± 1.46) (P < 0.05). …”
  4. 564
  5. 565

    Cell viability (a) and perforation efficiency (b) for different radiant exposures and irradiation times. by Stefan Kalies (388164)

    Published 2015
    “…<p>Viability was evaluated with a calcein/propidium iodide assay one hour after perforation. …”
  6. 566
  7. 567
  8. 568
  9. 569

    Venous ulcer healing treated with conventional therapy and adjuvant laser: is there a difference? by Viviane Maria Osmarin (12688063)

    Published 2022
    “…<div><p>ABSTRACT Objectives: to evaluate the effects of venous ulcer healing in patients after six months of conventional treatment and adjuvant low-power laser therapy. Methods: prospective cohort study nested in a randomized clinical trial with 38 patients, allocated into an intervention group (conventional treatment and adjuvant laser therapy) and a control group (conventional treatment). …”
  10. 570
  11. 571
  12. 572
  13. 573
  14. 574
  15. 575
  16. 576
  17. 577
  18. 578
  19. 579
  20. 580

    Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA. by Stefano Farioli-Vecchioli (256006)

    Published 2009
    “…<p>(<b>A–D</b>) A PC12 cell line carrying an inducible <i>PC3</i> (rat) cDNA under control of the tet-off system (i.e., a tetracycline responsive element TRE-PC3, activated by a tetracycline-regulated transactivator, CMV-tTA, in the absence of doxycycline) was used to analyze the binding of <i>PC3</i> to the <i>Id3</i> promoter, by chromatin immunoprecipitation (ChIP). …”